Johanna Richter

701 total citations · 1 hit paper
25 papers, 265 citations indexed

About

Johanna Richter is a scholar working on Public Health, Environmental and Occupational Health, Molecular Biology and Hematology. According to data from OpenAlex, Johanna Richter has authored 25 papers receiving a total of 265 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Public Health, Environmental and Occupational Health, 7 papers in Molecular Biology and 7 papers in Hematology. Recurrent topics in Johanna Richter's work include Streptococcal Infections and Treatments (7 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers) and Chronic Myeloid Leukemia Treatments (4 papers). Johanna Richter is often cited by papers focused on Streptococcal Infections and Treatments (7 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers) and Chronic Myeloid Leukemia Treatments (4 papers). Johanna Richter collaborates with scholars based in Germany, Australia and United Kingdom. Johanna Richter's co-authors include Mark J. Walker, Amanda J. Cork, Stephan Brouwer, Anita Badbaran, Nicolaus Kröger, Nico Gagelmann, Francis Ayuk, Victor Nizet, Jens Kühle and Christoph Heesen and has published in prestigious journals such as New England Journal of Medicine, Nature Communications and Blood.

In The Last Decade

Johanna Richter

20 papers receiving 262 citations

Hit Papers

CD19-targeted chimeric an... 2024 2026 2024 25 50 75
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. CD19-targeted chimeric antigen receptor T cell therapy in two patients with multiple sclerosis
    2024 78 citations Johanna Richter, Boris Fehse et al. Med profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Johanna Richter Germany 9 97 86 82 59 45 25 265
Ravisankar Rajarethinam Singapore 9 98 1.0× 91 1.1× 102 1.2× 97 1.6× 68 1.5× 19 309
Fiorella Rossi United States 9 24 0.2× 124 1.4× 48 0.6× 98 1.7× 83 1.8× 10 329
Shevaun P. Davis Canada 9 119 1.2× 98 1.1× 21 0.3× 37 0.6× 155 3.4× 9 338
Chunlin Zhang China 8 200 2.1× 57 0.7× 45 0.5× 142 2.4× 9 0.2× 15 365
Rachel N. Cotton United States 11 54 0.6× 58 0.7× 26 0.3× 24 0.4× 189 4.2× 15 333
Madeline Yung United States 9 75 0.8× 142 1.7× 36 0.4× 14 0.2× 18 0.4× 18 410
Siggeir F. Brynjólfsson Iceland 11 20 0.2× 90 1.0× 45 0.5× 45 0.8× 211 4.7× 19 375
Carolina Caro‐Vegas United States 8 20 0.2× 134 1.6× 124 1.5× 116 2.0× 111 2.5× 10 431
Patrick O’Rourke United States 4 129 1.3× 69 0.8× 41 0.5× 129 2.2× 115 2.6× 7 304
Helen C. O’Neill United Kingdom 11 87 0.9× 83 1.0× 11 0.1× 16 0.3× 67 1.5× 25 308

Countries citing papers authored by Johanna Richter

Since Specialization
Citations

This map shows the geographic impact of Johanna Richter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johanna Richter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johanna Richter more than expected).

Fields of papers citing papers by Johanna Richter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johanna Richter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johanna Richter. The network helps show where Johanna Richter may publish in the future.

Co-authorship network of co-authors of Johanna Richter

This figure shows the co-authorship network connecting the top 25 collaborators of Johanna Richter. A scholar is included among the top collaborators of Johanna Richter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johanna Richter. Johanna Richter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gagelmann, Nico, Johanna Richter, Radwan Massoud, et al.. (2025). Belumosudil for Chronic Graft-Versus-Host Disease: A Systematic Review and Meta-Analysis. Transplantation and Cellular Therapy.
2.
3.
Gagelmann, Nico, Anita Badbaran, Johanna Richter, et al.. (2025). Clearance of Driver Mutations after Transplantation for Myelofibrosis. New England Journal of Medicine. 392(2). 150–160. 1 indexed citations
4.
Rampotas, Alexandros, Johanna Richter, David Isenberg, & Claire Roddie. (2024). CAR-T cell therapy embarks on autoimmune disease. Bone Marrow Transplantation. 60(1). 6–9. 13 indexed citations
5.
6.
Richter, Johanna, Boris Fehse, Stefanie Reinhardt, et al.. (2024). CD19-Directed CAR T Cell Therapy in 4 Patients with Refractory Multiple Sclerosis. Blood. 144(Supplement 1). 2073–2073. 1 indexed citations
7.
Richter, Johanna, et al.. (2024). Exploring the therapeutic potential of autologous hematopoietic stem cell transplantation in progressive multiple sclerosis—a systematic review. European Journal of Neurology. 31(12). e16427–e16427. 2 indexed citations
8.
Rivera-Hernández, Tania, Diane G. Carnathan, Johanna Richter, et al.. (2024). Efficacy of Alum-Adjuvanted Peptide and Carbohydrate Conjugate Vaccine Candidates against Group A Streptococcus Pharyngeal Infection in a Non-Human Primate Model. Vaccines. 12(4). 382–382.
9.
Richter, Johanna, Boris Fehse, Stefanie Reinhardt, et al.. (2024). CD19-targeted chimeric antigen receptor T cell therapy in two patients with multiple sclerosis. Med. 5(6). 550–558.e2. 78 indexed citations breakdown →
10.
Richter, Johanna, Amanda J. Cork, Nadia Keller, et al.. (2024). Characterization of a novel covS SNP identified in Australian group A Streptococcus isolates derived from the M1 UK lineage. mBio. 16(2). e0336624–e0336624. 1 indexed citations
11.
Gagelmann, Nico, Christine Wolschke, Anita Badbaran, et al.. (2024). Graft-versus-host disease and impact on relapse in myelofibrosis undergoing hematopoietic stem cell transplantation. Bone Marrow Transplantation. 59(4). 550–557. 8 indexed citations
12.
13.
14.
Gagelmann, Nico, Anita Badbaran, Claudia Langebrake, et al.. (2024). Clinical and Immune Effects of Peri‐Transplantation JAK Inhibition for Myelofibrosis. American Journal of Hematology. 100(2). 200–209. 1 indexed citations
15.
Richter, Johanna, et al.. (2023). Benefits of aHSCT over alemtuzumab in patients with multiple sclerosis besides disability and relapses: Sustained improvement in cognition and quality of life. Multiple Sclerosis and Related Disorders. 82. 105414–105414. 2 indexed citations
16.
Ossendorff, Robert, et al.. (2023). The Validity of Motion Capture Analysis System against the Gold Standard Long-Standing Radiography in the Measurement of Lower Extremity Alignment. Journal of Clinical Medicine. 12(2). 567–567. 2 indexed citations
17.
Richter, Johanna, Stephan Brouwer, Kate Schroder, & Mark J. Walker. (2021). Inflammasome activation and IL ‐1β signalling in group A Streptococcus disease. Cellular Microbiology. 23(9). e13373–e13373. 8 indexed citations
18.
Brouwer, Stephan, Timothy C. Barnett, Katherine J. Kasper, et al.. (2020). Prophage exotoxins enhance colonization fitness in epidemic scarlet fever-causing Streptococcus pyogenes. Nature Communications. 11(1). 5018–5018. 44 indexed citations
19.
Chagraoui, Hédia, Maiken Søndergaard Kristiansen, Juan Pablo Ruíz, et al.. (2018). SCL/TAL1 cooperates with Polycomb RYBP-PRC1 to suppress alternative lineages in blood-fated cells. Nature Communications. 9(1). 5375–5375. 26 indexed citations
20.
Szczepanowski, Monika, Johanna Richter, Matthias Ritgen, et al.. (2018). CD20 Expression and Response to Rituximab Treatment in B-Cell Precursor Lymphoblastic Leukemia - Results of the GMALL 08/2013 Trial. Blood. 132(Supplement 1). 1409–1409. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ravisankar Rajarethinam Breakdown of academic impact, for papers by Fiorella Rossi Breakdown of academic impact, for papers by Shevaun P. Davis Breakdown of academic impact, for papers by Chunlin Zhang Breakdown of academic impact, for papers by Rachel N. Cotton Breakdown of academic impact, for papers by Madeline Yung Breakdown of academic impact, for papers by Siggeir F. Brynjólfsson Breakdown of academic impact, for papers by Carolina Caro‐Vegas Breakdown of academic impact, for papers by Patrick O’Rourke Breakdown of academic impact, for papers by Helen C. O’Neill
Rankless by CCL
2026